The NIHR Birmingham Biomedical Research Centre (BRC) opened on 1 April 2017 with the aim of accelerating the access to, and adoption of, drugs, devices and diagnostics tests for patients living with chronic inflammatory disease, driven by cutting edge experimental medicine.
The University of Birmingham has purchased 9.9acres of land in the Selly Oak area to develop a brand new Life Sciences Park.
Research led by University of Birmingham scientists has found that people suffering from the adrenal disorder known as Addison's disease suffer from an immune system defect that makes them prone to potentially deadly respiratory infections.
Leading scientists and clinicians from across the UK have conducted an analysis of global research into the care of hospital patients with dementia and delirium, and are recommending a radical review of patient care.
The success of a five year study into potential biomarkers indicative of traumatic brain injury has led to additional funding for a portable diagnostic tool, and a collaboration with the USA.